Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial

Objective: To determine whether, in acute non-ST elevation coronary syndrome, the benefit from early invasive coronary intervention compared with a conservative strategy of later symptom-guided intervention varies over time. Methods: In RITA 3 (Randomised Intervention Trial of unstable Angina 3) pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart (British Cardiac Society) 2006-10, Vol.92 (10), p.1473-1479
Hauptverfasser: Poole-Wilson, P A, Pocock, S J, Fox, K A A, Henderson, R A, Wheatley, D J, Chamberlain, D A, Shaw, T R D, Clayton, T C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1479
container_issue 10
container_start_page 1473
container_title Heart (British Cardiac Society)
container_volume 92
creator Poole-Wilson, P A
Pocock, S J
Fox, K A A
Henderson, R A
Wheatley, D J
Chamberlain, D A
Shaw, T R D
Clayton, T C
description Objective: To determine whether, in acute non-ST elevation coronary syndrome, the benefit from early invasive coronary intervention compared with a conservative strategy of later symptom-guided intervention varies over time. Methods: In RITA 3 (Randomised Intervention Trial of unstable Angina 3) patients were randomly assigned to coronary angiography (median 2 days after randomisation) and appropriate intervention (n  =  895) or to a symptom-guided conservative strategy (n  =  915). Results: In the first week patients in both groups were at highest risk of death, myocardial infarction (MI) or refractory angina (incidence rate 40 times higher than in months 5–12 of follow up). There were 22 MIs and 6 deaths in the intervention group (largely due to procedure-related events, 14 MIs and 3 deaths) versus 17 MIs and 3 deaths in the conservative group. In the rest of the year there were an additional 12 versus 27 MIs, respectively (treatment–time interaction p  =  0.021). Over one year in the intervention group there was a 43% reduction in refractory angina; 22% of patients underwent coronary artery bypass surgery and 35% underwent percutaneous coronary intervention only, which reduced refractory angina but provoked some early MIs; and 43% were still treated medically, mostly because of a favourable initial angiogram. Conclusion: Any intervention policy needs to recognise the high risk of events in the first week and the substantial minority of patients not needing intervention. Intervention may be best targeted at higher risk patients, as the early hazards of the procedure are then offset by reduced subsequent events.
doi_str_mv 10.1136/hrt.2005.060541
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1861054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68861951</sourcerecordid><originalsourceid>FETCH-LOGICAL-b522t-7c82818bdb4c63ec30762b0e11d48d566c269fe6aafce8f79ad1b77aa8399dba3</originalsourceid><addsrcrecordid>eNqFkk2P0zAQhiMEYpeFMzdkCcEBKV07aRxnD0irio9KC0hLQb1ZE2eyTUnsYrsV_Vf8RCa02gUunGzNPPP6Hc8kyVPBJ0Lk8nzl4yTjvJhwyYupuJeciqlUacbF8j7d86JIJc_Lk-RRCGvO-bRS8mFyIqTMhFLZafJzbiP6HdrYOQs926EP28CMs4HCELsdsugR4kAI6ywDs43IrLPp5wXDHkfGWSrwVO_3LOxt492AFyx2A1J86wMy17INgaPGABZu8Lcc2IY1XUAgAkcPgTkywJxFtkfw43txhex6vrhkOfnooH-cPGihD_jkeJ4lX96-Wczep1ef3s1nl1dpXWRZTEujMiVU3dRTI3M0OS9lVnMUopmqppDSZLJqUQK0BlVbVtCIuiwBVF5VTQ35WfL6oLvZ1gM2htx56PXGdwO1qR10-u-M7Vb6xu20UFLQLEjg5VHAu-9bDFEPXTDY92DRbYOWisCqEAQ-_wdc06fRMIIWpeKy4rkaqfMDZbwLwWN7a0VwPe6Cpl3Q4y7owy5QxbM_O7jjj8Mn4MURgGCgbz1Y04U7Tomi4LIkLj1wXYj44zYP_pumbFnoj19nelnlH5alEvqa-FcHvh7W_3X5C4FF3iA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780690381</pqid></control><display><type>article</type><title>Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Poole-Wilson, P A ; Pocock, S J ; Fox, K A A ; Henderson, R A ; Wheatley, D J ; Chamberlain, D A ; Shaw, T R D ; Clayton, T C</creator><creatorcontrib>Poole-Wilson, P A ; Pocock, S J ; Fox, K A A ; Henderson, R A ; Wheatley, D J ; Chamberlain, D A ; Shaw, T R D ; Clayton, T C ; Randomised Intervention Trial of unstable Angina Investigators</creatorcontrib><description>Objective: To determine whether, in acute non-ST elevation coronary syndrome, the benefit from early invasive coronary intervention compared with a conservative strategy of later symptom-guided intervention varies over time. Methods: In RITA 3 (Randomised Intervention Trial of unstable Angina 3) patients were randomly assigned to coronary angiography (median 2 days after randomisation) and appropriate intervention (n  =  895) or to a symptom-guided conservative strategy (n  =  915). Results: In the first week patients in both groups were at highest risk of death, myocardial infarction (MI) or refractory angina (incidence rate 40 times higher than in months 5–12 of follow up). There were 22 MIs and 6 deaths in the intervention group (largely due to procedure-related events, 14 MIs and 3 deaths) versus 17 MIs and 3 deaths in the conservative group. In the rest of the year there were an additional 12 versus 27 MIs, respectively (treatment–time interaction p  =  0.021). Over one year in the intervention group there was a 43% reduction in refractory angina; 22% of patients underwent coronary artery bypass surgery and 35% underwent percutaneous coronary intervention only, which reduced refractory angina but provoked some early MIs; and 43% were still treated medically, mostly because of a favourable initial angiogram. Conclusion: Any intervention policy needs to recognise the high risk of events in the first week and the substantial minority of patients not needing intervention. Intervention may be best targeted at higher risk patients, as the early hazards of the procedure are then offset by reduced subsequent events.</description><identifier>ISSN: 1355-6037</identifier><identifier>EISSN: 1468-201X</identifier><identifier>DOI: 10.1136/hrt.2005.060541</identifier><identifier>PMID: 16621882</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Cardiovascular Society</publisher><subject>acute coronary syndrome ; Adult ; Aged ; Angina pectoris ; Angina, Unstable - mortality ; Angina, Unstable - therapy ; Biological and medical sciences ; CABG ; Cardiology. Vascular system ; Cardiovascular disease ; Confidence intervals ; coronary angiography ; Coronary Artery Bypass ; coronary artery bypass graft ; Coronary heart disease ; Coronary vessels ; Female ; Fragmin and Fast Revascularisation during Instability in Coronary artery disease ; FRISC II ; Heart ; Heart attacks ; Humans ; ICTUS ; Interventional Cardiology and Surgery ; Invasive versus Conservative Treatment in Unstable Coronary Syndromes ; Male ; Medical imaging ; Medical sciences ; Middle Aged ; Mortality ; myocardial infarction ; Myocardial Infarction - etiology ; Myocardial Infarction - mortality ; myocardial ischaemia ; PCI ; percutaneous coronary intervention ; Platelet Glycoprotein GPIIb-IIIa Complex - antagonists &amp; inhibitors ; Randomised Intervention Trial of unstable Angina 3 ; Recurrence ; Risk Factors ; RITA 3 ; Survival Analysis ; TACTICS ; Treat angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy ; Treatment Outcome ; VANQWISH ; Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital</subject><ispartof>Heart (British Cardiac Society), 2006-10, Vol.92 (10), p.1473-1479</ispartof><rights>Copyright 2006 by Heart</rights><rights>2006 INIST-CNRS</rights><rights>Copyright: 2006 Copyright 2006 by Heart</rights><rights>Copyright © 2006 BMJ Publishing Group and British Cardiovascular Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b522t-7c82818bdb4c63ec30762b0e11d48d566c269fe6aafce8f79ad1b77aa8399dba3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://heart.bmj.com/content/92/10/1473.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://heart.bmj.com/content/92/10/1473.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,230,314,725,778,782,883,3185,23554,27907,27908,53774,53776,77351,77382</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18155067$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16621882$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poole-Wilson, P A</creatorcontrib><creatorcontrib>Pocock, S J</creatorcontrib><creatorcontrib>Fox, K A A</creatorcontrib><creatorcontrib>Henderson, R A</creatorcontrib><creatorcontrib>Wheatley, D J</creatorcontrib><creatorcontrib>Chamberlain, D A</creatorcontrib><creatorcontrib>Shaw, T R D</creatorcontrib><creatorcontrib>Clayton, T C</creatorcontrib><creatorcontrib>Randomised Intervention Trial of unstable Angina Investigators</creatorcontrib><title>Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial</title><title>Heart (British Cardiac Society)</title><addtitle>Heart</addtitle><description>Objective: To determine whether, in acute non-ST elevation coronary syndrome, the benefit from early invasive coronary intervention compared with a conservative strategy of later symptom-guided intervention varies over time. Methods: In RITA 3 (Randomised Intervention Trial of unstable Angina 3) patients were randomly assigned to coronary angiography (median 2 days after randomisation) and appropriate intervention (n  =  895) or to a symptom-guided conservative strategy (n  =  915). Results: In the first week patients in both groups were at highest risk of death, myocardial infarction (MI) or refractory angina (incidence rate 40 times higher than in months 5–12 of follow up). There were 22 MIs and 6 deaths in the intervention group (largely due to procedure-related events, 14 MIs and 3 deaths) versus 17 MIs and 3 deaths in the conservative group. In the rest of the year there were an additional 12 versus 27 MIs, respectively (treatment–time interaction p  =  0.021). Over one year in the intervention group there was a 43% reduction in refractory angina; 22% of patients underwent coronary artery bypass surgery and 35% underwent percutaneous coronary intervention only, which reduced refractory angina but provoked some early MIs; and 43% were still treated medically, mostly because of a favourable initial angiogram. Conclusion: Any intervention policy needs to recognise the high risk of events in the first week and the substantial minority of patients not needing intervention. Intervention may be best targeted at higher risk patients, as the early hazards of the procedure are then offset by reduced subsequent events.</description><subject>acute coronary syndrome</subject><subject>Adult</subject><subject>Aged</subject><subject>Angina pectoris</subject><subject>Angina, Unstable - mortality</subject><subject>Angina, Unstable - therapy</subject><subject>Biological and medical sciences</subject><subject>CABG</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular disease</subject><subject>Confidence intervals</subject><subject>coronary angiography</subject><subject>Coronary Artery Bypass</subject><subject>coronary artery bypass graft</subject><subject>Coronary heart disease</subject><subject>Coronary vessels</subject><subject>Female</subject><subject>Fragmin and Fast Revascularisation during Instability in Coronary artery disease</subject><subject>FRISC II</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>ICTUS</subject><subject>Interventional Cardiology and Surgery</subject><subject>Invasive versus Conservative Treatment in Unstable Coronary Syndromes</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>myocardial infarction</subject><subject>Myocardial Infarction - etiology</subject><subject>Myocardial Infarction - mortality</subject><subject>myocardial ischaemia</subject><subject>PCI</subject><subject>percutaneous coronary intervention</subject><subject>Platelet Glycoprotein GPIIb-IIIa Complex - antagonists &amp; inhibitors</subject><subject>Randomised Intervention Trial of unstable Angina 3</subject><subject>Recurrence</subject><subject>Risk Factors</subject><subject>RITA 3</subject><subject>Survival Analysis</subject><subject>TACTICS</subject><subject>Treat angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy</subject><subject>Treatment Outcome</subject><subject>VANQWISH</subject><subject>Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital</subject><issn>1355-6037</issn><issn>1468-201X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkk2P0zAQhiMEYpeFMzdkCcEBKV07aRxnD0irio9KC0hLQb1ZE2eyTUnsYrsV_Vf8RCa02gUunGzNPPP6Hc8kyVPBJ0Lk8nzl4yTjvJhwyYupuJeciqlUacbF8j7d86JIJc_Lk-RRCGvO-bRS8mFyIqTMhFLZafJzbiP6HdrYOQs926EP28CMs4HCELsdsugR4kAI6ywDs43IrLPp5wXDHkfGWSrwVO_3LOxt492AFyx2A1J86wMy17INgaPGABZu8Lcc2IY1XUAgAkcPgTkywJxFtkfw43txhex6vrhkOfnooH-cPGihD_jkeJ4lX96-Wczep1ef3s1nl1dpXWRZTEujMiVU3dRTI3M0OS9lVnMUopmqppDSZLJqUQK0BlVbVtCIuiwBVF5VTQ35WfL6oLvZ1gM2htx56PXGdwO1qR10-u-M7Vb6xu20UFLQLEjg5VHAu-9bDFEPXTDY92DRbYOWisCqEAQ-_wdc06fRMIIWpeKy4rkaqfMDZbwLwWN7a0VwPe6Cpl3Q4y7owy5QxbM_O7jjj8Mn4MURgGCgbz1Y04U7Tomi4LIkLj1wXYj44zYP_pumbFnoj19nelnlH5alEvqa-FcHvh7W_3X5C4FF3iA</recordid><startdate>20061001</startdate><enddate>20061001</enddate><creator>Poole-Wilson, P A</creator><creator>Pocock, S J</creator><creator>Fox, K A A</creator><creator>Henderson, R A</creator><creator>Wheatley, D J</creator><creator>Chamberlain, D A</creator><creator>Shaw, T R D</creator><creator>Clayton, T C</creator><general>BMJ Publishing Group Ltd and British Cardiovascular Society</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20061001</creationdate><title>Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial</title><author>Poole-Wilson, P A ; Pocock, S J ; Fox, K A A ; Henderson, R A ; Wheatley, D J ; Chamberlain, D A ; Shaw, T R D ; Clayton, T C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b522t-7c82818bdb4c63ec30762b0e11d48d566c269fe6aafce8f79ad1b77aa8399dba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>acute coronary syndrome</topic><topic>Adult</topic><topic>Aged</topic><topic>Angina pectoris</topic><topic>Angina, Unstable - mortality</topic><topic>Angina, Unstable - therapy</topic><topic>Biological and medical sciences</topic><topic>CABG</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular disease</topic><topic>Confidence intervals</topic><topic>coronary angiography</topic><topic>Coronary Artery Bypass</topic><topic>coronary artery bypass graft</topic><topic>Coronary heart disease</topic><topic>Coronary vessels</topic><topic>Female</topic><topic>Fragmin and Fast Revascularisation during Instability in Coronary artery disease</topic><topic>FRISC II</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>ICTUS</topic><topic>Interventional Cardiology and Surgery</topic><topic>Invasive versus Conservative Treatment in Unstable Coronary Syndromes</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>myocardial infarction</topic><topic>Myocardial Infarction - etiology</topic><topic>Myocardial Infarction - mortality</topic><topic>myocardial ischaemia</topic><topic>PCI</topic><topic>percutaneous coronary intervention</topic><topic>Platelet Glycoprotein GPIIb-IIIa Complex - antagonists &amp; inhibitors</topic><topic>Randomised Intervention Trial of unstable Angina 3</topic><topic>Recurrence</topic><topic>Risk Factors</topic><topic>RITA 3</topic><topic>Survival Analysis</topic><topic>TACTICS</topic><topic>Treat angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy</topic><topic>Treatment Outcome</topic><topic>VANQWISH</topic><topic>Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poole-Wilson, P A</creatorcontrib><creatorcontrib>Pocock, S J</creatorcontrib><creatorcontrib>Fox, K A A</creatorcontrib><creatorcontrib>Henderson, R A</creatorcontrib><creatorcontrib>Wheatley, D J</creatorcontrib><creatorcontrib>Chamberlain, D A</creatorcontrib><creatorcontrib>Shaw, T R D</creatorcontrib><creatorcontrib>Clayton, T C</creatorcontrib><creatorcontrib>Randomised Intervention Trial of unstable Angina Investigators</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Heart (British Cardiac Society)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poole-Wilson, P A</au><au>Pocock, S J</au><au>Fox, K A A</au><au>Henderson, R A</au><au>Wheatley, D J</au><au>Chamberlain, D A</au><au>Shaw, T R D</au><au>Clayton, T C</au><aucorp>Randomised Intervention Trial of unstable Angina Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial</atitle><jtitle>Heart (British Cardiac Society)</jtitle><addtitle>Heart</addtitle><date>2006-10-01</date><risdate>2006</risdate><volume>92</volume><issue>10</issue><spage>1473</spage><epage>1479</epage><pages>1473-1479</pages><issn>1355-6037</issn><eissn>1468-201X</eissn><abstract>Objective: To determine whether, in acute non-ST elevation coronary syndrome, the benefit from early invasive coronary intervention compared with a conservative strategy of later symptom-guided intervention varies over time. Methods: In RITA 3 (Randomised Intervention Trial of unstable Angina 3) patients were randomly assigned to coronary angiography (median 2 days after randomisation) and appropriate intervention (n  =  895) or to a symptom-guided conservative strategy (n  =  915). Results: In the first week patients in both groups were at highest risk of death, myocardial infarction (MI) or refractory angina (incidence rate 40 times higher than in months 5–12 of follow up). There were 22 MIs and 6 deaths in the intervention group (largely due to procedure-related events, 14 MIs and 3 deaths) versus 17 MIs and 3 deaths in the conservative group. In the rest of the year there were an additional 12 versus 27 MIs, respectively (treatment–time interaction p  =  0.021). Over one year in the intervention group there was a 43% reduction in refractory angina; 22% of patients underwent coronary artery bypass surgery and 35% underwent percutaneous coronary intervention only, which reduced refractory angina but provoked some early MIs; and 43% were still treated medically, mostly because of a favourable initial angiogram. Conclusion: Any intervention policy needs to recognise the high risk of events in the first week and the substantial minority of patients not needing intervention. Intervention may be best targeted at higher risk patients, as the early hazards of the procedure are then offset by reduced subsequent events.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Cardiovascular Society</pub><pmid>16621882</pmid><doi>10.1136/hrt.2005.060541</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1355-6037
ispartof Heart (British Cardiac Society), 2006-10, Vol.92 (10), p.1473-1479
issn 1355-6037
1468-201X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1861054
source MEDLINE; BMJ Journals - NESLi2; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects acute coronary syndrome
Adult
Aged
Angina pectoris
Angina, Unstable - mortality
Angina, Unstable - therapy
Biological and medical sciences
CABG
Cardiology. Vascular system
Cardiovascular disease
Confidence intervals
coronary angiography
Coronary Artery Bypass
coronary artery bypass graft
Coronary heart disease
Coronary vessels
Female
Fragmin and Fast Revascularisation during Instability in Coronary artery disease
FRISC II
Heart
Heart attacks
Humans
ICTUS
Interventional Cardiology and Surgery
Invasive versus Conservative Treatment in Unstable Coronary Syndromes
Male
Medical imaging
Medical sciences
Middle Aged
Mortality
myocardial infarction
Myocardial Infarction - etiology
Myocardial Infarction - mortality
myocardial ischaemia
PCI
percutaneous coronary intervention
Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors
Randomised Intervention Trial of unstable Angina 3
Recurrence
Risk Factors
RITA 3
Survival Analysis
TACTICS
Treat angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy
Treatment Outcome
VANQWISH
Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital
title Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T09%3A18%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interventional%20versus%20conservative%20treatment%20in%20acute%20non-ST%20elevation%20coronary%20syndrome:%20time%20course%20of%20patient%20management%20and%20disease%20events%20over%20one%20year%20in%20the%20RITA%203%20trial&rft.jtitle=Heart%20(British%20Cardiac%20Society)&rft.au=Poole-Wilson,%20P%20A&rft.aucorp=Randomised%20Intervention%20Trial%20of%20unstable%20Angina%20Investigators&rft.date=2006-10-01&rft.volume=92&rft.issue=10&rft.spage=1473&rft.epage=1479&rft.pages=1473-1479&rft.issn=1355-6037&rft.eissn=1468-201X&rft_id=info:doi/10.1136/hrt.2005.060541&rft_dat=%3Cproquest_pubme%3E68861951%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1780690381&rft_id=info:pmid/16621882&rfr_iscdi=true